english.prescrire.org > Topics > Advancing healthcare policy > Transparent, independent health authorities > Actions vis-à-vis regulatory agencies > No to EMA's provision of confidential scientific advice to drug companies (11/2017)

Advancing healthcare policy

Transparent, independent health authorities

Transparent, independent health authorities: Actions vis-à-vis regulatory agencies
No to EMA's provision of confidential scientific advice to drug companies (November 2017)

Paris, 28 November 2017

Prescrire, along with around 20 civil society organisations, has signed a joint declaration drawing attention to potential problems posed by the provision of confidential scientific advice by the European Medicines Agency to pharmaceutical companies, especially a decline in regulatory standards, a risk of institutional capture, and a total lack of transparency surrounding the activity of European regulatory authorities.

> Click here to download the joint declaration (413 Ko)


©Prescrire November 2017